Brian Schwartz

Insider Reports History

Location
Burlington, MA
Signature
/s/ Brian Schwartz
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian Schwartz:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cyclacel Pharmaceuticals, Inc. Interim Chief Medical Officer, Director Common Stock 15,205 $50,405 $3.32 29 Jan 2024 Direct
INFINITY PHARMACEUTICALS, INC. Director Common Stock 30,919 $2,164 $0.0700 16 Jun 2022 Direct
INFINITY PHARMACEUTICALS, INC. Director Stock Option(right to buy) 45,000 16 Jun 2022 Direct
Cyclacel Pharmaceuticals, Inc. Interim Chief Medical Officer, Director Stock Option (right to buy) 12,500 29 Jan 2024 Direct

Insider Reports Filed by Brian Schwartz

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CYCC Cyclacel Pharmaceuticals, Inc. 29 Jan 2024 2 $0 4 Interim Chief Medical Officer, Director 31 Jan 2024, 16:56
CYCC Cyclacel Pharmaceuticals, Inc. 30 Jun 2023 2 $0 4 Director 03 Jul 2023, 16:55
/report/000114036122023308-schwartz-brian-2022-06-16 INFINITY PHARMACEUTICALS, INC. 16 Jun 2022 2 +$20,994 4 Director 16 Jun 2022, 20:32
CYCC Cyclacel Pharmaceuticals, Inc. 14 Jun 2022 2 $0 4 Director 16 Jun 2022, 16:11
/report/000114036121030894-schwartz-brian-2021-09-07 INFINITY PHARMACEUTICALS, INC. 07 Sep 2021 1 $0 4 Director 10 Sep 2021, 12:35
/report/000114036121030892-schwartz-brian-2021-09-07 INFINITY PHARMACEUTICALS, INC. 07 Sep 2021 0 $0 3 Director 10 Sep 2021, 12:30
CYCC Cyclacel Pharmaceuticals, Inc. 15 Jun 2021 4 $0 4 Director 17 Jun 2021, 16:07